New drug for acute migraine attacks
10/01/2020
![](https://duyn491kcolsw.cloudfront.net/files/1c/1c8/1c8sfe.jpg?ph=1409f0aae3)
Ubrogepant is the first drug in the calcitonin-related peptide receptor antagonist class approved for the acute treatment of migraine.